The Most Effective, Efficient, and Clinically Proven Devices for Treating Nail Fungus, Acne, and More
Proven by exceptional clinical research – most credible certifications on the market.
Quick & Convenient
Non-invasive 10 – 30 minute treatments with no reported side effects.
Make your investment back in months. We’ll help you at every stage.
Erchonia’s non-thermal lasers are the only Low-Level Laser Therapy (LLLT) devices to be FDA Market Cleared for treating nail fungus (onychomycosis) and acne – FDA Level One (510k) clearance is the ‘gold standard’, requiring placebo controlled, double blind, randomised, and multi-centre studies. The treatments are short, effective, and easy to administer. There is no associated pain, reported side effects, or downtime, and the technology is safe with no health risks. We provide the training, ongoing support, and marketing, so you can focus on what matters most – your clients.
Erchonia’s Lunula® Laser is the only LLLT device to be FDA Market Cleared for treating fungal nail infections.
Lunula® is easy to set up and use, and is the only automated system on the market today, allowing you to save on staff costs and increase profits.
The device targets onychomycosis through the use of two true laser beams (red 635nm and violet 405nm – monochromatic, collimated, and coherent), providing outstanding results in short 12 minute treatments.
The two wavelengths trigger a photochemical reaction, producing Reactive Oxygen Species which is converted to Hydrogen Peroxide – a natural antiseptic that kills onychomycosis. In addition, the red 635nm wavelength induces the production of Adenosine Triphosphate (ATP) which is converted to Nitric Oxide – aiding the natural immune response in fighting the infection.
The EVRL® Laser is a cordless handheld device with a simple graphic interface and preset / customisable protocols. It is the only LLLT device to be FDA Market Cleared for treating acne and bacterial, fungal, or viral infections, and is efficacious for pain management.
EVRL® utilises true laser technology, optimising photonic energy delivery through the use of monochromatic, collimated, and coherent beams of light. The device emits two true laser beams – a violet laser provides an antimicrobial effect through its 405nm line coherent beam (5mW output), and a red laser promotes healing through its 635nm line coherent beam (7.5mW output).
Used on its own or as an adjunct, EVRL® is effective for a wide variety of conditions, allowing you to expand your treatment range and grow your clinic.
Why Choose Erchonia®?
World Leaders in Laser Therapy Technology
With over 25 years of experience, 16,000+ devices in the market, and 18 FDA-clearances, Erchonia® Corporation are world leaders in Laser Therapy technology. Our range of non-thermal Low-Level Laser Therapy (LLLT) devices are used in many areas, including pain relief, fat removal, cellulite reduction, fungal nail treatment, and more. Based in the UK, Erchonia Lasers Ltd are a subsidiary organisation. We provide personal support to companies in Europe, Middle East, and Africa… Read More
91% Customer Satisfaction Rating
Our clients say it all: best products, service, training, and support.
Over 25 Years of Experience
Founded in 1996 – first Low-Level Laser in the world to gain FDA market clearance.
18 FDA (Level One 510k) Clearances
Proven by placebo controlled, double blind, randomised, and multi-centre studies.
16,000+ Devices in the Market
Leaders in the field with over $5 million invested in R&D at any one time.